Dr Kathleen O'hara Johnson, MD | |
6330 Riverdale Rd, Riverdale, GA 30274-1617 | |
(770) 994-7400 | |
Not Available |
Full Name | Dr Kathleen O'hara Johnson |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 6330 Riverdale Rd, Riverdale, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386922441 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 40426 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kathleen O'hara Johnson, MD 6330 Riverdale Rd, Riverdale, GA 30274-1617 Ph: (770) 994-7400 | Dr Kathleen O'hara Johnson, MD 6330 Riverdale Rd, Riverdale, GA 30274-1617 Ph: (770) 994-7400 |
News Archive
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
Cancer cells may be able to avoid destruction by anti-vascular and anti-angiogenesis agents through a cellular stress response that activates a pro-survival protein called GRP78, according to researchers from the Keck School of Medicine of the University of Southern California.
People with dementia often have behavioral symptoms. These include problems with memory, language, and decision-making abilities. People with dementia can also experience changes in mood, such as increased irritability, depression, and anxiety.
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
The Nencki Institute of Experimental Biology in Warsaw launches research programs, which require state-of-the-art magnetic resonance scanner.
› Verified 3 days ago
Dr. Jay R Prakash, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 6555 Professional Pl, Suite C, Riverdale, GA 30274 Phone: 770-996-5959 Fax: 770-991-1596 | |
Dr. Hymavati Mikkilineni, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 483 Upper Riverdale Rd Sw, Suite B, Riverdale, GA 30274 Phone: 770-994-0242 Fax: 770-994-4386 | |
Paul L Harvey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 483 Upper Riverdale Rd Sw Ste G, Riverdale, GA 30274 Phone: 770-996-9400 Fax: 770-991-2918 | |
Dr. Isaac V Joseph, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 6555 Professional Pl, Suite D, Riverdale, GA 30274 Phone: 770-994-7700 Fax: 770-997-8399 | |
Dr. Eloy Edilberto Diaz Sr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6572 River Park Dr Ste 102, Riverdale, GA 30274 Phone: 770-629-2296 | |
Rajinikanth Seshan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 253 Upper Riverdale Rd Sw, Suite B, Riverdale, GA 30274 Phone: 216-533-8842 | |
Dr. Victor Ezinna Okeh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 483 Upper Riverdale Rd Sw Ste F, Riverdale, GA 30274 Phone: 770-742-3883 Fax: 855-597-8504 |